Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255

Watchlist Manager
Hebei Changshan Biochemical Pharmaceutical Co Ltd Logo
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Watchlist
Price: 55.8 CNY -0.14% Market Closed
Market Cap: 51.3B CNY

Profitability Summary

Hebei Changshan Biochemical Pharmaceutical Co Ltd's profitability score is 20/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

20/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

20/100
Profitability
Score
20/100
Profitability
Score

Margins

Earnings Waterfall
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Margins Comparison
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
51.3B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.3B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
51.3B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate